RT Journal Article
SR Electronic
T1 Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: clinical outcomes and translational biomarker analyses
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003853
DO 10.1136/jitc-2021-003853
VO 10
IS 1
A1 Friedman, Claire F
A1 Spencer, Christine
A1 Cabanski, Christopher R
A1 Panageas, Katherine S
A1 Wells, Daniel K
A1 Ribas, Antoni
A1 Tawbi, Hussein
A1 Tsai, Katy
A1 Postow, Michael
A1 Shoushtari, Alexander
A1 Chapman, Paul
A1 Karakunnel, Joyson
A1 Bucktrout, Samantha
A1 Gherardini, Pier
A1 Hollmann, Travis J
A1 Chen, Richard O
A1 Callahan, Margaret
A1 LaVallee, Theresa
A1 Ibrahim, Ramy
A1 Wolchok, Jedd
YR 2022
UL http://jitc.bmj.com/content/10/1/e003853.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.